Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in france: Comparisons of resident characteristics and physician attitude

Journal of the American Geriatrics Society

Volumn 63, Issue 1, 2015, Pages 71-76

  Bahri, Oarda ^a   Roca, Frederic ^a   Lechani, Tarik ^b   Druesne, Laurent ^a   Jouanny, Pierre ^c   Serot, Jean Marie ^c   Boulanger, Eric ^b   Puisieux, Francois ^b   Chassagne, Philippe ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Anticoagulation; Atrial fibrillation; Nursing home

Indexed keywords

ANTICOAGULANT AGENT;

AGED; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FRANCE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NURSING HOME PATIENT; PHYSICIAN; PHYSICIAN ATTITUDE; QUESTIONNAIRE; ATRIAL FIBRILLATION; CLINICAL PRACTICE; CLINICAL TRIAL; GERIATRIC ASSESSMENT; HEALTH PERSONNEL ATTITUDE; MULTICENTER STUDY; NURSING HOME; ORAL DRUG ADMINISTRATION; PREVALENCE; PSYCHOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; GERIATRIC ASSESSMENT; HUMANS; MALE; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PREVALENCE; RISK FACTORS;

EID: 84925238599     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13200     Document Type: Article

References (32)

1. Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375.
2. Conen D, Chae CU, Glynn RJ et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA 2011;305:2080-2087.
3. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
5. Kalantarian S, Stern TA, Mansour M et al. Cognitive impairment associated with atrial fibrillation: A meta-analysis. Ann Intern Med 2013;158:338-346.
6. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354.
7. Hylek EM, Go AS, Chang Y et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-1026.
8. Reardon G, Nelson WW, Patel AA et al. Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: Evidence of continuing low use despite consideration of stroke and bleeding risk. Drugs Aging 2013;30:417-428.
9. January CT, Wann LS, Alpert JS et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014. doi: 10.1016/j.jacc.2014.03.022 [Epub ahead of print.]
10. Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870.
11. Ogilvie IM, Newton N, Welner SA et al. Underuse of oral anticoagulants in atrial fibrillation: A systematic review. Am J Med 2010;123:638-645.e4.
12. Olsen TS, Rasmussen BH, Kammersgaard LP et al. Strokes attributable to underuse of warfarin and antiplatelets. J Stroke Cerebrovasc Dis 2005;14:55-57.
13. Rozzini R, Sleiman I, Trabucchi M. Warfarin prescribing in nursing homes. J Am Geriatr Soc 2011;59:183-184.
14. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
15. Lip GY, Frison L, Halperin JL et al. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011;57:173-180.
16. Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114:119-125.
17. Ewen E, Zhang Z, Simon TA et al. Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices. Vasc Health Risk Manag 2012;8:587-598.
18. McCormick D, Gurwitz JH, Goldberg RJ et al. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001;161:2458-2463.
19. Poli D, Antonucci E, Testa S et al. Bleeding risk in very old patients on vitamin K antagonist treatment: Results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation. Circulation 2011;124:824-829.
20. Gage BF, Birman-Deych E, Kerzner R et al. Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med 2005;118:612-617.
21. Marinigh R, Lip GY, Fiotti N et al. Age as a risk factor for stroke in atrial fibrillation patients implications for thromboprophylaxis: Implications for thromboprophylaxis. J Am Coll Cardiol 2010;56:827-837.
22. Hart RG, Pearce LA, Rothbart RM et al. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000;35:183-187.
23. Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med 1994;121:442-451.
24. Rubenstein LZ. Preventing falls in the nursing home. JAMA 1997;278:595-596.
25. Fang MC, Go AS, Chang Y et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007;120:700-705.
26. Singer DE, Chang Y, Fang MC et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 2009;151:297-305.
27. Man-Son-Hing M, Nichol G, Lau A et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999;159:677-685.
28. Camm AJ, Lip GY, de Caterina R et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-2747.
29. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: Recent data and ideas. Stroke 2005;36:1588-1593.
30. Bond AJ, Molnar FJ, Li M et al. The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy. Thromb J 2005;3:1.
31. DiMarco JP, Flaker G, Waldo AL et al. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:650-656.
32. Torn M, Bollen WL, van der Meer FJ et al. Risks of oral anticoagulant therapy with increasing age. Arch Intern Med 2005;165:1527-1532.